| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/09513590903366996 |
| P698 | PubMed publication ID | 20222840 |
| P2093 | author name string | Vincenzo Benedetto | |
| Emanuela Raffone | |||
| Pietro Rizzo | |||
| P2860 | cites work | Metformin in polycystic ovary syndrome: systematic review and meta-analysis | Q22242098 |
| Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome | Q22250886 | ||
| Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome | Q28142499 | ||
| Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome | Q28271889 | ||
| Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome | Q28294415 | ||
| Insulin-signaling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology | Q30460829 | ||
| Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial | Q34011558 | ||
| Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). | Q34285382 | ||
| Involvement of inositol in reproduction | Q34573998 | ||
| Insulin sensitizers for polycystic ovary syndrome | Q35155109 | ||
| Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? | Q35776475 | ||
| Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome | Q35893431 | ||
| Diagnostic criteria for polycystic ovarian syndrome | Q36690960 | ||
| Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective | Q36808872 | ||
| Dermatologic manifestations of polycystic ovary syndrome | Q36888959 | ||
| Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome | Q36951616 | ||
| Second messengers of insulin action | Q37850168 | ||
| Mediators of postreceptor action of insulin | Q40133250 | ||
| Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome | Q42497234 | ||
| Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality | Q42521935 | ||
| Metformin for the treatment of the polycystic ovary syndrome | Q44934959 | ||
| Treatment of hirsutism with myo-inositol: a prospective clinical study | Q46317562 | ||
| Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome | Q46706686 | ||
| Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction | Q46938213 | ||
| Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. | Q51557405 | ||
| Polycystic Ovary Syndrome | Q56092373 | ||
| P433 | issue | 4 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 275-280 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Gynecological Endocrinology | Q5625187 |
| P1476 | title | Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women | |
| P478 | volume | 26 |
| Q59336976 | A randomized controlled trial comparing lifestyle intervention to letrozole for ovulation in women with polycystic ovary syndrome: a study protocol |
| Q24200558 | Antioxidants for female subfertility |
| Q38655692 | Antioxidants for female subfertility. |
| Q34546109 | Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients |
| Q34001931 | Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: prevalence and patient characteristics. |
| Q36249155 | Does ovary need D-chiro-inositol? |
| Q28073603 | Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials |
| Q34030482 | Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials |
| Q55209426 | Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. |
| Q90660997 | Inositol for subfertile women with polycystic ovary syndrome |
| Q34557177 | Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials |
| Q38901819 | Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives |
| Q97524388 | Inositols and metabolic disorders: From farm to bedside |
| Q39001562 | Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome |
| Q48349236 | Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study. |
| Q47421851 | Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial |
| Q37232396 | Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study. |
| Q33775146 | Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols |
| Q35639510 | Polycystic ovary syndrome: chemical pharmacotherapy |
| Q34036909 | The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial |
| Q38231822 | The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome |
| Q47198726 | The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review |
| Q38217670 | Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome |
Search more.